Impact of converging sociocultural and substance-related trends on US autism rates: combined geospatiotemporal and causal inferential analysis.

This large study looked at autism diagnosis rates across the US from 1991-2011 and compared them with cannabis use patterns. Researchers found statistical links between cannabis use (especially daily use and use during early pregnancy) and higher autism diagnosis rates. The study suggests these associations might be strong enough to influence overall autism trends, though this type of research cannot prove cannabis causes autism.

This epidemiological study analyzed US autism rates from 1991-2011 alongside national drug exposure data, examining 266,950 autistic individuals among 40+ million 8-year-olds. The research found statistical associations between cannabis use and autism spectrum diagnosis rates (ASMR) at both national and state levels. Daily cannabis use and first trimester pregnancy exposure showed significant correlations with higher autism rates. Specific cannabinoid compounds (THC and cannabigerol) demonstrated exponential relationships with ASMR in geospatial modeling.

The authors report high E-values and claim the relationship satisfies causal inference criteria, though this remains an observational study with inherent limitations in establishing causation.

While this study suggests associations between cannabis use and autism diagnosis rates, clinicians should interpret cautiously. The observational design cannot prove causation. However, the findings may warrant discussion of prenatal cannabis exposure risks with expectant mothers as part of comprehensive prenatal counseling, pending further research validation.

This is an observational study that cannot establish causation despite authors' claims. Potential confounding factors, diagnostic changes over time, increased autism awareness, and ecological fallacy concerns limit interpretation. The relationship between population-level cannabis use and individual autism diagnoses remains unclear.

Whilst cannabis is known to be toxic to brain development, it is unknown if it is driving rising US autism rates (ASMR). A longitudinal epidemiological study was conducted using national autism census data from the US Department of Education Individuals with Disabilities Act (IDEA) 1991-2011 and nationally representative drug exposure (cigarettes, alcohol, analgesic, and cocaine abuse, and cannabis use monthly, daily, and in pregnancy) datasets from National Survey of Drug Use and Health and US Census (income and ethnicity) and CDC Wonder population and birth data. Analysis was conducted in R. 266,950 were autistic of a population of 40,119,464 8-year-olds in 1994-2011. At national level after adjustment, daily cannabis use was significantly related to ASMR (β estimate = 4.37 (95%C.I. 4.06, 4.68), P < 2.2 × 10) as was first pregnancy trimester cannabis exposure (β estimate = 0.12 (0.08, 0.16), P = 1.7 × 10).

At state level following adjustment for cannabis, cannabigerol (from β estimate = - 13.77 (- 19.41, 8.13), P = 1.8 × 10) and Δ9-tetrahydrocannabinol (from β estimate = 1.96 (0.88-3.04), P = 4 × 10) were significant. Geospatial state-level modelling showed exponential relationship between ASMR and Δ9-tetrahydrocannabinol and cannabigerol exposure. Exponential coefficients for the relationship between modelled ASMR and Δ9-tetrahydrocannabinol and cannabigerol exposure were 7.053 (6.39-7.71) and 185.334 (167.88-202.79; both P < 2.0 × 10). E-values are an instrument related to the evidence for causality in observational studies.

High E-values were noted. Dichotomized legal status was linked with elevated ASMR. Data show cannabis use is associated with ASMR, is powerful enough to affect overall trends, and persists after controlling for other major covariates. Cannabinoids are exponentially associated with ASMR.

The cannabis-autism relationship satisfies criteria of causal inference.